 |
 |
MediGene’s Veregen® launched by Solvay in Germany more |
 |
 |
MediGene and Teva sign agreement to commercialize Veregen™ in Israel more |
 |
 |
MediGene nominates Dr. Thomas Werner to the Supervisory Board more |
 |
 |
MediGene AG presents future business plan at annual analyst conference more |
 |
 |
|
 |
Drugs for the market

MediGene's vision is the expansion of the potentials in medicine
by means of utilizing biotechnology in a responsible manner.
We apply state-of-the-art technologies in the development of
innovative drugs for the treatment of cancer and autoimmune
diseases. MediGene pursues the strategy of integrating all core
areas of a modern biopharmaceuticals company from research to
drug development and commercialization.
|
 |
|